Effects of canagliflozin on weight loss in high-fat diet-induced obese mice

Canagliflozin, an inhibitor of sodium glucose co-transporter (SGLT) 2, has been shown to reduce body weight during the treatment of type 2 diabetes mellitus (T2DM). In this study, we sought to determine the role of canagliflozin in body weight loss and liver injury in obesity. C57BL/6J mice were fed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Wenjun, Zhao, Mei, Wang, Meng, Yan, Wenhui, Liu, Yuan, Ren, Shuting, Lu, Jun, Wang, Bing, Chen, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493335/
https://www.ncbi.nlm.nih.gov/pubmed/28665967
http://dx.doi.org/10.1371/journal.pone.0179960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493335/
https://www.ncbi.nlm.nih.gov/pubmed/28665967
http://dx.doi.org/10.1371/journal.pone.0179960

Ejemplares similares